Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Co(II) and Fe(II) Mixed Ligand Complexes of Pefloxacin and Ascorbic Acid:Synthesis, Characterization and Antibacterial Studies


Affiliations
1 Department of Chemistry, Michael Okpara University of Agriculture, Umudike, Umuahia, Abia State, Nigeria
2 Department of Pure and Industrial Chemistry, Abia State University, Uturu, Abia State, Nigeria
     

   Subscribe/Renew Journal


Mixed ligand metal complexes of 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid (pefloxacin) and ascorbic acid were synthesized using Fe(II) and Co(II). The mixed ligand complexes were characterized by IR, UV-Vis., 1H and 13C NMR spectroscopy to determine the complexation behaviour of the metal ions towards the mixed ligand. The yield, melting point, colour and solubility were determined. Electronic spectra of the mixed ligand complexes show intra ligand charge transfer, ligand to metal charge transfer and d-d transition. Based on the spectroscopic data obtained, the mixed complexes were proposed to have the formulae: [Fe(PfAs)]x and [Co(PfAs)]; Pf = pefloxacin and As = Ascorbic acid. The spectral studies of the mixed ligand complexes suggest that in the complexes, pefloxacin and ascorbic acid behaved as tridentate ligands coordinating through the two carbonyl oxygen atom and oxygen atom of the hydroxyl group in pefloxacin, while ascorbic acid coordinated through the oxygen of the carbonyl and enolic C-2 and C-3 hydroxyl groups. Octahedral structure was proposed for [Fe(PfAs)]x and [Co(PfAs)]x. The antibacterial activity of the ligand and the mixed ligand complexes was carried out against both gram positive and gram negative bacterial species which include; Staphylococcus aureus, E. coli., Bacillus subtilis, Pseudominas Spp. and Candida Spp. at 0.1g. The zone of inhibition of the pefloxacin-ascorbic acid mixed ligand complexes were significantly higher (P < 0.05) than the free ligands.

Keywords

Pefloxacin, Synthesis, Mixed Ligand, Complexes, Antibacterial.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 180

PDF Views: 3




  • Co(II) and Fe(II) Mixed Ligand Complexes of Pefloxacin and Ascorbic Acid:Synthesis, Characterization and Antibacterial Studies

Abstract Views: 180  |  PDF Views: 3

Authors

U. Onyenze
Department of Chemistry, Michael Okpara University of Agriculture, Umudike, Umuahia, Abia State, Nigeria
I. E. Otuokere
Department of Chemistry, Michael Okpara University of Agriculture, Umudike, Umuahia, Abia State, Nigeria
J. C. Igwe
Department of Pure and Industrial Chemistry, Abia State University, Uturu, Abia State, Nigeria

Abstract


Mixed ligand metal complexes of 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid (pefloxacin) and ascorbic acid were synthesized using Fe(II) and Co(II). The mixed ligand complexes were characterized by IR, UV-Vis., 1H and 13C NMR spectroscopy to determine the complexation behaviour of the metal ions towards the mixed ligand. The yield, melting point, colour and solubility were determined. Electronic spectra of the mixed ligand complexes show intra ligand charge transfer, ligand to metal charge transfer and d-d transition. Based on the spectroscopic data obtained, the mixed complexes were proposed to have the formulae: [Fe(PfAs)]x and [Co(PfAs)]; Pf = pefloxacin and As = Ascorbic acid. The spectral studies of the mixed ligand complexes suggest that in the complexes, pefloxacin and ascorbic acid behaved as tridentate ligands coordinating through the two carbonyl oxygen atom and oxygen atom of the hydroxyl group in pefloxacin, while ascorbic acid coordinated through the oxygen of the carbonyl and enolic C-2 and C-3 hydroxyl groups. Octahedral structure was proposed for [Fe(PfAs)]x and [Co(PfAs)]x. The antibacterial activity of the ligand and the mixed ligand complexes was carried out against both gram positive and gram negative bacterial species which include; Staphylococcus aureus, E. coli., Bacillus subtilis, Pseudominas Spp. and Candida Spp. at 0.1g. The zone of inhibition of the pefloxacin-ascorbic acid mixed ligand complexes were significantly higher (P < 0.05) than the free ligands.

Keywords


Pefloxacin, Synthesis, Mixed Ligand, Complexes, Antibacterial.